enGene Therapeutics Inc.
ENGN
$1.70
$0.010.59%
NASDAQ
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.89% | 29.06% | -18.71% | -21.64% | -17.91% |
| Total Receivables | 448.22% | 759.77% | 115.79% | 194.19% | -56.06% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -14.42% | 18.68% | -32.51% | 83.36% | 184.16% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.17% | -1.33% | 9.72% | -4.00% | -4.00% |
| Total Current Assets | 18.43% | 30.09% | -18.58% | -19.56% | -15.44% |
|
|
|||||
| Total Current Assets | 18.43% | 30.09% | -18.58% | -19.56% | -15.44% |
| Net Property, Plant & Equipment | 195.65% | 224.21% | 250.27% | 251.21% | 8.46% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -12.12% | -0.87% | -0.14% | 41.03% |
| Total Assets | 15.33% | 17.90% | -28.83% | -7.99% | -2.51% |
|
|
|||||
| Total Accounts Payable | 14.42% | -6.53% | 373.99% | -16.70% | 642.65% |
| Total Accrued Expenses | 40.20% | 155.82% | 23.32% | 17.91% | 116.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -38.02% | 18.99% | 792.69% | 293.59% | 850.36% |
| Total Finance Division Other Current Liabilities | 14.00% | -64.65% | 164.89% | 192.06% | 176.82% |
| Total Other Current Liabilities | 14.00% | -64.65% | 164.89% | 192.06% | 176.82% |
| Total Current Liabilities | 19.35% | 89.96% | 118.12% | 51.88% | 185.78% |
|
|
|||||
| Total Current Liabilities | 19.35% | 89.96% | 118.12% | 51.88% | 185.78% |
| Long-Term Debt | 24.41% | 14.01% | -31.81% | -18.07% | -11.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 346.18% | 367.47% | 352.35% | 354.86% | -12.85% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 33.02% | 54.43% | 39.41% | 22.79% | 28.79% |
|
|
|||||
| Common Stock & APIC | 29.04% | 28.95% | 2.24% | 13.86% | 13.67% |
| Retained Earnings | -41.57% | -43.83% | -46.05% | -39.56% | -35.46% |
| Treasury Stock & Other | -17.75% | 33.96% | 37.42% | -19.00% | 4.63% |
| Total Common Equity | 12.26% | 12.64% | -38.48% | -12.88% | -6.45% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 12.26% | 12.64% | -38.48% | -12.88% | -6.45% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 12.26% | 12.64% | -38.48% | -12.88% | -6.45% |
|
|
|||||